Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia

INTRODUCTION: The clinical efficiency of cefoperazone/sulbactam (CPZ/SUL) against Escherichia coli bacteremia was unknown. This study aimed to explore the relationship between CPZ/SUL MIC values and clinical outcomes in Escherichia coli bacteremia. METHODS: A multicenter, retrospective, observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shang-Yi, Lu, Po-Liang, Wu, Ting-Shu, Shie, Shian-Sen, Chang, Feng-Yee, Yang, Ya-Sung, Chiang, Tsung-Ta, Wang, Fu-Der, Ho, Mao-Wang, Chou, Chia-Hui, Liu, Jien-Wei, Shi, Zhi-Yuan, Chuang, Yin-Ching, Tang, Hung-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617991/
https://www.ncbi.nlm.nih.gov/pubmed/35864347
http://dx.doi.org/10.1007/s40121-022-00672-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617991/
https://www.ncbi.nlm.nih.gov/pubmed/35864347
http://dx.doi.org/10.1007/s40121-022-00672-2

Ejemplares similares